Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in the United Kingdom: A National Cohort Study, March 2020 to January 2021.

"Drs. Dennis and Mateen’s institutions received funding from Diabetes UK. Dr. Dennis received support for article research from Diabetes UK. Dr. McGovern’s institution received funding from Eli Lilly and Company, Pfizer, and AstraZeneca. Drs. Thomas and Mateen received support for article research from Wellcome Trust/Charities Open Access Fund. Dr. Thomas disclosed that he is a Wellcome funded PhD student. Dr. Vollmer received funding from IQVIA; he received support for article research from Research Councils UK. Dr. Mateen disclosed that he is an employee of Wellcome Trust and holds a Wellcome funded honorary post at University College London for the purposes of carrying out independent research; the views expressed in this article do not necessarily reflect the views of the Wellcome Trust. Dr. Dennis is supported by a Research England’s Expanding Excellence in England Independent Fellowship. Mr. Wilde is supported by the Feuer International Scholarship in Artificial Intelligence. Drs. Vollmer and Mateen are supported by The Alan Turing Institute (Engineering and Physical Science Research Council grant EP/N510129/). Dr. Vollmer is supported by the University of Warwick Impact Acceleration Account funding. Dr. Thomas is funded by a Wellcome funded GW4 Clinical Academic Training programme (GW4-CAT) PhD Fellowship (220601/Z/20/Z). Dr. Wilde has disclosed that he does not have any potential conflicts of interest."

"This study was supported, in part, by Diabetes UK. The funder had no role in the design of the study, the analysis, or the formulation of the article. Drs. Dennis and Mateen’s institutions received funding from Diabetes UK. Dr. Dennis received support for article research from Diabetes UK. Dr. McGovern’s institution received funding from Eli Lilly and Company, Pfizer, and AstraZeneca. Drs. Thomas and Mateen received support for article research from Wellcome Trust/Charities Open Access Fund. Dr. Thomas disclosed that he is a Wellcome funded PhD student. Dr. Vollmer received funding from IQVIA; he received support for article research from Research Councils UK. Dr. Mateen disclosed that he is an employee of Wellcome Trust and holds a Wellcome funded honorary post at University College London for the purposes of carrying out independent research; the views expressed in this article do not necessarily reflect the views of the Wellcome Trust. Dr. Dennis is supported by a Research England’s Expanding Excellence in England Independent Fellowship. Mr. Wilde is supported by the Feuer International Scholarship in Artificial Intelligence. Drs. Vollmer and Mateen are supported by The Alan Turing Institute (Engineering and Physical Science Research Council grant EP/N510129/). Dr. Vollmer is supported by the University of Warwick Impact Acceleration Account funding. Dr. Thomas is funded by a Wellcome funded GW4 Clinical Academic Training programme (GW4-CAT) PhD Fellowship (220601/Z/20/Z). Dr. Wilde has disclosed that he does not have any potential conflicts of interest. The study was reviewed and approved by the Warwick Biomedical & Scientific Research Ethics Committee (BSREC) (BSREC 120/19-20-V1.0) and sponsorship is being provided by University of Warwick (SOC.28/19-20)."